Skip to main content
logo
Sharp Therapeutics Corp. (TSXV:SHRX)
Canada flag Canada · Delayed Price · Currency is CAD
1.370
0.00 (0.00%)
At close: Sep 8, 2026

Sharp Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
437530--
Market Cap Growth
44.33%153.22%---
Enterprise Value
467450--
Last Close Price
1.372.501.051.05-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
-13.96-309.887.97--
P/TBV Ratio
--7.97--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
-1.03-7.260.51-1.10-1.15
Net Debt / Equity Ratio
-0.99-1.85-0.84-1.06-1.13
Net Debt / EBITDA Ratio
-0.39-0.060.86-5.46-3.78
Net Debt / FCF Ratio
-0.49-0.070.60-6.20-4.36
Quick Ratio
0.051.005.050.050.04
Current Ratio
0.071.065.100.060.05
Return on Equity (ROE)
-3762.21%-512.77%---
Return on Assets (ROA)
-131.63%-105.91%-52.06%-95.55%-
Return on Capital Employed (ROCE)
482.60%-552.80%-65.80%36.70%86.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-17.01%-11.28%-15.83%--
FCF Yield
-14.22%-8.83%-17.63%--
Buyback Yield / Dilution
-28.61%-227.37%-107.12%-3028.62%-